| Literature DB >> 32821523 |
Kamron N Khan1,2,3,4, Shyamanga Borooah1,5, Leonardo Lando6, Kunny Dans5, Omar A Mahroo1,2, Amit Meshi5, Angelos Kalitzeos1,2, Georgios Agorogiannis1, Sasan Moghimi6, William R Freeman5, Andrew R Webster1,2, Anthony T Moore2,7, Martin McKibbin3,4, Michel Michaelides1,2.
Abstract
Purpose: To describe and quantify Bruch's membrane (BM) and retinal pigment epithelium (RPE) separation using spectral-domain (SD) optical coherence tomography (OCT) in patients affected by inherited macular degenerations associated with BM thickening.Entities:
Keywords: inherited macular degeneration; macular degeneration; optical coherence tomography; retinal dystrophy
Mesh:
Year: 2020 PMID: 32821523 PMCID: PMC7409156 DOI: 10.1167/tvst.9.6.26
Source DB: PubMed Journal: Transl Vis Sci Technol ISSN: 2164-2591 Impact factor: 3.283
Figure 1.OCT scans and plot profile measurements of BM-RPE separation. Examples are shown for a normal control (A, B), an early-stage dystrophic eye with L-ORD (C, D), and a late-stage case of DD (E, F). A horizontal Spectralis SD-OCT line scan through the central fovea was analyzed for each eye of every patient and control. Readings were taken 100 µm either side of the foveola for subfoveal measurements, and 1000 µm either side of the central fovea for juxtafoveal measurements (A, C, E). A line was generated across the outer retina. The insets show the representative lines that were used to generate the intensity plot profiles at the farthest right juxtafoveal location (B, D, F). Intensity plot profiles across the outer retina highlight the position of the ELM, EZ, IZ, RPE, and BM. The horizontal arrows highlight the BM to RPE separation in the case plot profiles (D, F).
Figure 2.SD-OCT scans identifies distinctive separation of the RPE (black arrowheads) from BM (white arrowheads) in patients diagnosed with SFD (A), DD (B), and late-onset macular degeneration (C). The green line highlights the position of the B-scan represented in the left hand images.
Clinical Features of SFD
| Early Stage | Intermediate Stage | Late Stage | |
|---|---|---|---|
| None | Poor vision in dark with good central vision | Poor vision in dark with reduced central vision | |
| 2 eyes (1 patient) | 12 eyes (6 patients) | 20 eyes (10 patients) | |
| 39 (6.7) | 45 (7.2) | 47.8 (8.6) | |
| No | Yes | Yes | |
| 0 +/− 0 µm | 34.4 +/− 52.4 µm | 23.8 +/− 7.3 µm | |
| 0 +/− 0 µm | 69.0 +/ −47.8 µm | 58.1 +/− 45.7 µm | |
| N/A | 0.042 (subfoveal) and 0.008 (juxtafoveal) |
Figure 3.(A) Measurement of BM-RPE separation in patients with SFD. There was a significant difference in mean BM-RPE separation between patients with early-stage (n = 2 eyes) and those with intermediate-stage disease (n = 12 eyes) at both sub- and juxtafoveal loci (P < 0.05 and 0.05, respectively). There was also a significant increase in mean BM-RPE separation at both sub- and juxtafoveal loci as the disease progressed from intermediate- to late-stage disease (n = 20 eyes) (P < 0.01 and 0.01, respectively). (B) BM-RPE separation in patients with DD. The distance between BM and the RPE was significantly greater in late-stage patients (n = 24 eyes) when compared with early-stage individuals (n = 10 eyes) at sub- and juxtafoveal loci (P < 0.001 and 0.001, respectively). (C) Measurement of BM-RPE separation in patients with L-ORD. There appears to be no significant difference in mean BM-RPE separation between patients with intermediate-stage (n = 6 eyes) or late-stage disease (n = 10 eyes) at either sub- or juxtafoveal locations. All three graphs are shown with standard deviation bars.
Clinical Features of DD
| Early Stage | Late Stage | |
|---|---|---|
| 20 eyes (10 patients) | 24 eyes (12 patients) | |
| 41 (9.7) | 58 (10.7) | |
| Yes | Yes | |
| 43.0 +/− 29.1 µm | 92.7 +/− 54.7 µm | |
| 78.5 +/− 74.3 µm | 108.9 +/− 57.1 µm | |
Clinical Features of L-ORD
| Intermediate Stage | Late Stage | |
|---|---|---|
| 6 eyes (3 patients) | 12 eyes (6 patients) | |
| 46.8 (2.3) | 67 (4.0) | |
| Yes | No | |
| 24.1 +/− 7.19 µm | 25.4 +/− 7.7 µm | |
| 26.0 +/− 9.3 µm | 22.1 +/− 7.1 µm | |
| 0.761 (subfoveal) and 0.250 (juxtafoveal) | ||